Danish Medicines Agency on family firm rulebreaking: There have been problems for years
On Wednesday, the Danish Medicines Agency revoked some elements of the family-owned medicine producer Scanpharm's license due to long-term problems with the company's quality control.
Around once every two years, the Danish Medicines Agency deems it neccessary to revoke a Danish pharmaceutical company's license, and on Wednesday it happened again.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
